Clinical trial
S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic…
NCT00217659 · SWOG Cancer Research Network, Other · Withdrawn
Key facts
| NCT number | NCT00217659 |
|---|---|
| Title | S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer |
| Official title | A Phase II Study of Goserelin Plus Anastrozole for the Treatment of Male Patients With Hormone-Receptor Positive Metastatic or Recurrent Breast Cancer |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | anastrozole, goserelin acetate |
| Enrollment | 0 |
| Start date | Sep 1, 2005 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Jan 3, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: